Cardinal Health ( (CAH) ) has released its Q1 earnings. Here is a breakdown of the information Cardinal Health presented to its investors.
Claim 50% Off TipRanks Premium and Invest with Confidence
- Unlock hedge-fund level data and powerful investing tools designed to help you make smarter, sharper decisions
- Stay ahead of the market with the latest news and analysis so your portfolio is always positioned for maximum potential
Cardinal Health, Inc., headquartered in Ohio, is a global healthcare services and products company that provides pharmaceuticals and medical products to various healthcare facilities, enhancing supply chain efficiency and integrated care coordination. In its latest quarterly earnings report, Cardinal Health announced a 22% increase in revenue, reaching $64 billion, driven by growth in branded and specialty pharmaceutical sales. The company’s GAAP operating earnings rose by 18% to $668 million, while non-GAAP operating earnings increased by 37% to $857 million, primarily due to acquisitions and increased contributions from pharmaceutical products. The Pharmaceutical and Specialty Solutions segment saw a 23% revenue increase, while the Global Medical Products and Distribution segment grew by 2%. Cardinal Health’s management remains optimistic about future growth, with expectations of continued demand for its products and services, despite potential challenges from regulatory changes and market conditions.